Zusammenfassung
Bei Human-immunodeficiency-virus (HIV)-positiven Patienten konnten durch die Einführung der hochaktiven antiretroviralen Therapie (HAART) viele opportunistische Infektionen durch Bakterien und Pilze zurückgedrängt werden. Bei den durch humanes Papilloma-Virus (HPV) ausgelösten Erkrankungen zeigt sich jedoch seit der Einführung der HAART zum Teil eine Zunahme. Es handelt sich dabei um das Analkarzinom sowie dessen Vorstufe, die anale intraepitheliale Neoplasie (AIN), die bei HIV-Patienten vermehrt auftritt. Ebenso kommt es vermehrt zum Zervixkarzinom und dessen Vorstufen sowie zu oralen Warzen und Kondylomen. Um eine AIN frühzeitig zu erkennen, müssen HIV-Patienten regelmäßig proktologisch untersucht werden. Dabei sollten für eine optimale Diagnostik eine Anoskopie, die der Kolposkopie entspricht, sowie Abstriche zur zytologischen Diagnostik durchgeführt werden.
Abstract
Since the introduction of highly active antiretroviral therapy (HAART), opportunistic infections by bacteria and fungi have been reduced in human immunodeficiency virus (HIV)-positive patients. However, diseases caused by human papilloma virus (HPV) have become more frequent despite HAART. There is an increased incidence of anal and cervical carcinomas, their precancerous lesions such as anal/cervical intraepithelial neoplasia, and condylomas and oral warts. In order to prevent anal carcinomas, HIV-positive patients should receive proctoscopic examinations regularly. The examination should include anoscopy and smears for cytology and HPV polymerase chain reaction.
Literatur
Anderson CA, Boller AM, Richardson CJ et al. (2004) Anal condyloma: a comparison between HIV positive and negative patients. Am surg 70: 1014–1018
Bleeker MC, Hogewoning CJ, Voorhorst FJ et al. (2003) Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 107: 804–810
Breese PL, Judson FN, Penley KA, Douglas JM Jr (1995) Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22: 7–14
Cameron JE, Mercante D, O’Brien M et al. (2005) The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 32: 703–709
Chin-Hong PV, Palefsky JM (2005) Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther 18: 67–76
Chin-Hong PV, Palefsky JM (2002) Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 35: 1127–1134
Conley LJ, Ellerbrock TV, Bush TJ et al. (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359: 108–113
Dasbach EJ, Elbasha EH, Insinga RP (2006) Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev 28: 88–100
Einstein MH, Kadish AS (2004) Anogenital neoplasia in AIDS. Curr Op Oncol 16: 455–462
Ellerbrock TV, Chiasson MA, Bush TJ et al. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. Jama 283: 1031–1037
Fenger C, Nielsen VT (1986) Precancerous changes in the anal canal epithelium in resection specimens. Acta Pathol Microbiol Immunol Scand 94: 63–69
Fox PA, Seet JE, Stebbing J et al. (2005) The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 81: 142–146
Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Nat Can Inst 92: 1500–1510
Hagensee ME, Cameron JE, Leigh JE, Clark RA (2004) Human papillomavirus infection and disease in HIV-infected individuals. Am J Med Scie 328:57–63
Hogewoning CJ, Bleeker MC, van den Brule AJ et al. (2003) Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 107: 811–816
Karlsson R, Jonsson M, Edlund K et al. (1995) Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 22: 119–127
Koshiol JE, Schroeder JC, Jamieson DJ et al. (2006) Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer
Kreuter A, Brockmeyer NH, Hochdorfer B et al. (2005) Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 52: 603–608
Kreuter A, Brockmeyer NH, Weissenborn SJ et al. (2006) 5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata. Arch Dermatol 142: 243–244
Lillo FB, Lodini S, Ferrari D et al. (2005) Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 40: 451–457
Massad LS, Evans CT, Minkoff H et al. (2004) Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstetri Gynecol 104: 1077–1085
Melbye M, Rabkin C, Frisch M, Biggar RJ (1994) Changing patterns of anal cancer incidence in the United States, 1940–1989. Am Epidemiol 139: 772–780
Nappi L, Carriero C, Bettocchi S et al. (2005) Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur J Obstet Gyn Reprod Biol 121: 226–232
Palefsky JM (2003) Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr op oncol 15:382–388
Palefsky JM, Holly EA, Efirdc JT et al. (2005) Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19: 1407–1414
Palefsky JM, Holly EA, Ralston ML, Jay N (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177: 361–367
Piketty C, Darragh TM, Da Costa M et al. (2003) High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Int Med 138:453–459
Steenbergen RD, de Wilde J, Wilting SM et al. (2005) HPV-mediated transformation of the anogenital tract. J Clin Virol 32 [Suppl] 1: 25–33
Wilkin TJ, Palmer S, Brudney KF et al. (2004) Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190: 1685–1691
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wienecke, R., Brockmeyer, N.H. & Kreuter, A. HPV-induzierte Erkrankungen bei HIV-positiven Patienten. Hautarzt 57, 994–998 (2006). https://doi.org/10.1007/s00105-006-1236-2
Issue Date:
DOI: https://doi.org/10.1007/s00105-006-1236-2